[ESPR] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -30.32%
YoY- -26.60%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 32,250 33,969 25,786 24,329 18,818 18,980 18,841 42.95%
PBT -56,344 -41,250 -49,935 -61,719 -55,487 -55,117 -66,324 -10.27%
Tax -27,424 -26 -51 27,501 12,974 13,494 13,948 -
NP -56,344 -41,250 -49,935 -89,220 -68,461 -68,611 -80,272 -20.96%
Tax Rate - - - - - - - -
Total Cost 88,594 75,219 75,721 113,549 87,279 87,591 99,113 -7.18%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -174.71 -121.43 -193.65 -366.72 -363.81 -361.49 -426.05 -44.71%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.50 -0.37 -0.46 -1.14 -0.93 -1.01 -1.27 -46.19%
EPS Diluted -0.50 -0.37 -0.46 -1.14 -0.93 -1.01 -1.27 -46.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.